S

Researcher Profile

Silja Sanden

1

Publications

223

Citations

10

Co-Authors

1

Active Years

Publications

Journal Article The Lancet Dec 01, 2023

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H Rovin · Jonathan Barratt · Hiddo J L Heerspink · Charles E Alpers +713 more

10.1016/s0140-6736(23)02302-4 223 citations

Publication Timeline

2023

1

Frequent Co-Authors

Lina Santockiene

Ivon Maritza Bobadilla Rico

Raul Fernandez Prado